| Financial Year |
March 31 2023 |
| Monetary Funds |
1,995,439,218.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
70,253,456.00 |
| Advances to Suppliers |
874,677,177.51 |
| Other Receivables |
37,060,388.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,483,526,369.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
168,677,585.81 |
| Total Current Assets |
8,211,832,194.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
175,486,412.33 |
| Investment Properties |
-- |
| Fixed Assetes |
25,878,749,946.88 |
| Under-construction Projects |
1,142,602,847.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,495,817,778.53 |
| R&D expenses |
-- |
| Goodwill |
328,054,770.34 |
| Long-Term Deferred and Prepaid Expenses |
228,994.73 |
| Deferred Income Tax Assets |
350,574,758.11 |
| Other Non-Current Assets |
735,594.37 |
| Sub-Total of Non-Current Assets |
30,728,594,934.91 |
| Total Assets |
38,940,427,129.72 |
| Short-Term Loans |
1,106,441,170.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
337,233,935.92 |
| Accounts Payable |
4,121,688,441.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
131,257,560.55 |
| Taxes Payable |
41,927,774.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,877,278,636.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,357,516,048.52 |
| Other Current Liabilities |
312,094,348.24 |
| Sub-Total of Current Liabilities |
12,686,203,455.34 |
| Long-term Loans |
3,241,745,100.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,355,466,022.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,171,252.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,015,214,750.54 |
| Total Liabilities |
17,701,418,205.88 |
| Paid-In Capital(Or Share Stock) |
8,918,602,267.00 |
| Capital Surplus |
19,282,146,606.55 |
| Surplus Reserve |
606,990,553.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-7,575,983,393.70 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,239,008,923.84 |
| Owner's Equity（Stockholder's Equity） |
21,239,008,923.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,940,427,129.72 |
